Last reviewed · How we verify
Propofol II
At a glance
| Generic name | Propofol II |
|---|---|
| Also known as | Propofol |
| Sponsor | Aarhus University Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Effects of an Opioid Free/Sparing Care Pathway for Patients Undergoing Obesity Surgery (NA)
- Anterior Quadratus Lumborum Block as a Component of Multimodal Analgesia for Abdominal Hysterectomies (NA)
- Perioperative Multimodal General AnesTHesia Focusing on Specific CNS Targets in Patients Undergoing carDiac surgERies (NA)
- Comparing the QoR of PECS Block and GA in Breast-conserving Surgery With Sentinel Lymph Node Biopsy (NA)
- Slow Wave Induction by Propofol to Eliminate Depression (SWIPED) Stage II (PHASE2)
- Comparison of The Effects Of General Anesthesia and PECS Block Methods on Blood Counts in Patients With Breast Cancer
- The Role of Oxygen Reserve Index (ORi) in Apneic Ventilation
- Opioid-free Anesthesia and Quality of Recovery After General Anesthesia
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Propofol II CI brief — competitive landscape report
- Propofol II updates RSS · CI watch RSS
- Aarhus University Hospital portfolio CI